Skip to main content
. 2022 Mar 3;2022(3):CD014328. doi: 10.1002/14651858.CD014328

NCT00562822.

Methods Study design: prospective single‐blind, single‐centre, parallel, two‐arm randomised controlled trial
Setting: London Health Sciences Centre ‐ University Hospital, London, Ontario, Canada
Trial time period: January 1999 to August 2007
Interventions: arthroscopic surgery plus optimised physical and medical therapy versus optimised physical and medical therapy
Sample size calculations: estimated enrolment of 188 participants, no sample size calculations reported
Analysis: not reported
Participants Inclusion Criteria
Idiopathic or secondary osteoarthritis of the knee with Grade 2 to 4 radiographic severity as defined by the modified Kellgren‐Lawrence classification
Exclusion Criteria
  • Participants with inflammatory or post‐infectious arthritis

  • Those who had undergone previous arthroscopic treatment for knee osteoarthritis

  • Those with isolate Grade III to IV medical compartment osteoarthritis with greater than 5 degrees of varus deformity

Interventions Arthroscopic surgery plus optimised physical and medical therapy: arthroscopic surgery to treat unresolved symptoms of osteoarthritis of the knee
Optimised physical and medical therapy: treatment with physical and medical therapy alone
Outcomes Primary outcome measures:
Function, pain and quality of life based on the WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) scores (time frame: 2 years)
Secondary outcome measures:
Health utility using the standard‐gamble technique (time frame: 24 months)
Notes Clinical trial registration:NCT00562822
Trial status: recruitment completed
Estimated study completion date: recruitment completed in August 2007; however, results not available yet